Progress in Alzheimer’s and Parkinson’s DiseasesAbraham Fisher, Israel Hanin, Mitsuo Yoshinda Springer Science & Business Media, 30 sept. 1998 - 888 pagini This book represents the fourth ina series of international conferences related to Alzheimer's (AD) and Parkinson's (PO) diseases. The first one took place in EHat, Israel in 1985; the second in Kyoto, Japan, in 1989; and the third in Chicago, IL, USA in 1993. This book incorporates the proceedings of the Fourth International Conference on Pro gress in Alzheimer's and Parkinson's Diseases, held in EHat, Israel, on May 18-23, 1997. This Conference was the 41st in the series of annual OHOLO Conferences sponsored by the Israel Institute for Biological Research (IIBR). It was also conducted under the aus pices of the Alzheimer's Association Ronald and Nancy Reagan Research Institute, USA. The Conference was attended by 550 participants from 28 countries, representing a broad spectrum of research interests; and included a well-balanced representation from aca demia, clinical institutions and pharmaceutical industry. The four-and-one-half day meeting served as an excellent medium for surveying the current preclinical and clinical develop ments in AD, PO, and other related disorders. The scientific program was divided into 24 oral sessions and daily poster sessions. The conference culminated in a round table discus sion. There were 122 talks and 161 posters. This book incorporates a combination of both. |
Cuprins
I | 1 |
II | 7 |
III | 13 |
IV | 17 |
V | 25 |
VI | 31 |
VII | 39 |
VIII | 45 |
LXVIII | 445 |
LXIX | 451 |
LXX | 463 |
LXXI | 469 |
LXXII | 477 |
LXXIII | 481 |
LXXIV | 487 |
LXXV | 495 |
XI | 53 |
XII | 59 |
XIII | 67 |
XIV | 77 |
XV | 81 |
XVI | 89 |
XVIII | 99 |
XIX | 105 |
XX | 113 |
XXI | 121 |
XXII | 133 |
XXIII | 141 |
XXIV | 149 |
XXV | 159 |
XXVI | 163 |
XXVII | 171 |
XXVIII | 177 |
XXIX | 183 |
XXX | 187 |
XXXI | 191 |
XXXII | 197 |
XXXIII | 205 |
XXXIV | 213 |
XXXV | 223 |
XXXVI | 235 |
XXXVII | 241 |
XXXVIII | 251 |
XXXIX | 257 |
XL | 265 |
XLI | 271 |
XLII | 277 |
XLIII | 287 |
XLIV | 293 |
XLV | 301 |
XLVI | 309 |
XLVIII | 317 |
XLIX | 323 |
L | 329 |
LI | 337 |
LII | 343 |
LIII | 351 |
LIV | 359 |
LV | 363 |
LVII | 371 |
LVIII | 377 |
LIX | 385 |
LX | 389 |
LXI | 393 |
LXII | 401 |
LXIII | 413 |
LXIV | 421 |
LXV | 429 |
LXVI | 435 |
LXVII | 439 |
LXXVI | 503 |
LXXVII | 509 |
LXXVIII | 515 |
LXXIX | 523 |
LXXX | 531 |
LXXXI | 541 |
LXXXIV | 551 |
LXXXV | 557 |
LXXXVII | 563 |
LXXXVIII | 571 |
LXXXIX | 579 |
XC | 587 |
XCI | 595 |
XCIII | 601 |
XCIV | 607 |
XCV | 615 |
XCVI | 627 |
XCVII | 635 |
XCVIII | 643 |
XCIX | 647 |
C | 653 |
CI | 661 |
CII | 675 |
CIII | 681 |
CIV | 687 |
CV | 695 |
CVIII | 699 |
CIX | 705 |
CX | 711 |
CXI | 717 |
CXII | 725 |
CXIII | 733 |
CXIV | 739 |
CXV | 747 |
CXVI | 751 |
CXVII | 757 |
CXIX | 765 |
CXX | 773 |
CXXI | 779 |
CXXII | 787 |
CXXIV | 793 |
CXXVI | 799 |
CXXVII | 805 |
CXXIX | 811 |
CXXX | 817 |
CXXXI | 823 |
CXXXIII | 829 |
CXXXIV | 833 |
CXXXV | 841 |
CXXXVI | 847 |
CXXXVII | 851 |
CXXXVIII | 861 |
867 | |
Alte ediții - Afișează-le pe toate
Progress in Alzheimer’s and Parkinson’s Diseases Abraham Fisher,Israel Hanin,Mitsuo Yoshinda Previzualizare limitată - 2012 |
Progress in Alzheimer’s and Parkinson’s Diseases Abraham Fisher,Israel Hanin,Mitsuo Yoshinda Nu există previzualizare disponibilă - 2011 |
Progress in Alzheimer’s and Parkinson’s Diseases Abraham Fisher,Israel Hanin,Mitsuo Yoshinda Nu există previzualizare disponibilă - 2012 |
Termeni și expresii frecvente
Acad acetylcholine acetylcholinesterase AChE acid activity agonists allele Alzheimer disease Alzheimer's and Parkinson's Alzheimer's disease amyloid amyloid precursor protein antibodies antioxidant apolipoprotein apoptosis Aẞ associated binding Biochem Biol Brain Res Cacabelos cell death cerebral Chem cholinergic cholinesterase clinical cognitive impairment cortex cortical cultures cybrids decrease deficits dementia disorders dopamine dopaminergic dose drug edited by Fisher effects enzyme Figure function gene genetic genotype hippocampus human huperzine increased induced inhibition inhibitors interaction isoforms lesions levels levodopa lipid membrane memory metabolism metrifonate mg/kg mice molecular mRNA muscarinic mutations Natl nerve growth factor Neurochem neurodegenerative Neurology neurons Neurosci neurotoxicity nicotinic NM(R)Sal normal oxidative Parkinson's disease Parkinson's Diseases edited pathology peptide phosphorylation plaques Plenum Press presenilin Proc Progress in Alzheimer's receptor reduced ẞ-amyloid striatum studies substantia nigra tacrine tau protein therapy tion tissue treatment vitro vivo